These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 9373618)

  • 1. The isoprostanes: unique bioactive products of lipid peroxidation.
    Morrow JD; Roberts LJ
    Prog Lipid Res; 1997 Mar; 36(1):1-21. PubMed ID: 9373618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The isoprostanes: unique prostaglandin-like products of free-radical-initiated lipid peroxidation.
    Morrow JD; Chen Y; Brame CJ; Yang J; Sanchez SC; Xu J; Zackert WE; Awad JA; Roberts LJ
    Drug Metab Rev; 1999 Feb; 31(1):117-39. PubMed ID: 10065368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel eicosanoids. Isoprostanes and related compounds.
    Roberts LJ; Brame CJ; Chen Y; Morrow JD
    Methods Mol Biol; 1999; 120():257-85. PubMed ID: 10343322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights into oxidative stress: the isoprostanes.
    Montuschi P; Barnes P; Roberts LJ
    Curr Med Chem; 2007; 14(6):703-17. PubMed ID: 17346157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The isoprostanes: unique bioactive products of lipid peroxidation. An overview.
    Liu TZ; Stern A; Morrow JD
    J Biomed Sci; 1998; 5(6):415-20. PubMed ID: 9845844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mass spectrometric quantification of F2-isoprostanes in biological fluids and tissues as measure of oxidant stress.
    Morrow JD; Roberts LJ
    Methods Enzymol; 1999; 300():3-12. PubMed ID: 9919502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo.
    Roberts LJ; Morrow JD
    Free Radic Biol Med; 2000 Feb; 28(4):505-13. PubMed ID: 10719231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Isoprostanes: new markers of oxidative stress. Fundamental and clinical aspects].
    Cracowski JL; Stanke-Labesque F; Bessard G
    Rev Med Interne; 2000 Mar; 21(3):304-7. PubMed ID: 10763198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The isoprostanes in biology and medicine.
    Praticò D; Lawson JA; Rokach J; FitzGerald GA
    Trends Endocrinol Metab; 2001 Aug; 12(6):243-7. PubMed ID: 11445440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The isoprostanes - unique products of arachidonate peroxidation: their role as mediators of oxidant stress.
    Morrow JD
    Curr Pharm Des; 2006; 12(8):895-902. PubMed ID: 16533158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in the biochemistry and clinical relevance of the isoprostane pathway.
    Musiek ES; Yin H; Milne GL; Morrow JD
    Lipids; 2005 Oct; 40(10):987-94. PubMed ID: 16382569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. F2-isoprostanes are not just markers of oxidative stress.
    Comporti M; Signorini C; Arezzini B; Vecchio D; Monaco B; Gardi C
    Free Radic Biol Med; 2008 Feb; 44(3):247-56. PubMed ID: 17997380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New techniques to detect oxidative stress markers: mass spectrometry-based methods to detect isoprostanes as the gold standard for oxidative stress in vivo.
    Yin H
    Biofactors; 2008; 34(2):109-24. PubMed ID: 19706977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of isoprostanes as indices of oxidant stress and the risk of atherosclerosis in humans.
    Morrow JD
    Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):279-86. PubMed ID: 15591226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The isoprostanes: novel prostaglandin-like products of the free radical-catalyzed peroxidation of arachidonic acid.
    Liu T; Stern A; Roberts LJ; Morrow JD
    J Biomed Sci; 1999; 6(4):226-35. PubMed ID: 10420080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isoprostanes: novel bioactive products of lipid peroxidation.
    Basu S
    Free Radic Res; 2004 Feb; 38(2):105-22. PubMed ID: 15104204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. F2-isoprostanes in Alzheimer and other neurodegenerative diseases.
    Montine TJ; Montine KS; McMahan W; Markesbery WR; Quinn JF; Morrow JD
    Antioxid Redox Signal; 2005; 7(1-2):269-75. PubMed ID: 15650414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of F2-isoprostanes by gas chromatography/mass spectrometry as a measure of oxidant stress.
    Musiek ES; Morrow JD
    Curr Protoc Toxicol; 2005 Jun; Chapter 17():Unit 17.6. PubMed ID: 23045115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Isoprostanes: new markers of oxidative stress in human diseases].
    Cracowski JL; Stanke-Labesque F; Souvignet C; Bessard G
    Presse Med; 2000 Mar; 29(11):604-10. PubMed ID: 10776418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isoprostanes and the kidney.
    Badr KF; Abi-Antoun TE
    Antioxid Redox Signal; 2005; 7(1-2):236-43. PubMed ID: 15650411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.